Table 3.
Demographic factors associated with phenotypic drug resistance of MTBC isolates
| Characteristics | Total N (%) | DR N (%) | Crude OR (95% CI) | Adjusted OR (95% CI) | P-value |
|---|---|---|---|---|---|
| Sex | |||||
| Female | 48 (38.1) | 7 (14.6) | 1.00 | 1.00 | |
| Male | 78 (61.9) | 7 (9.0) | 0.58 (0.19–1.76) | 0.55 (0.15–1.98) | 0.357 |
| Age in years | |||||
| 15–29 | 56 (44.4) | 6 (10.7) | 1.00 | 1.00 | |
| 30–44 | 48 (38.1) | 4 (8.3) | 0.76 (0.20–2.86) | 0.68 (0.16–2.86) | 0.601 |
| >=45 | 22 (17.5) | 4 (18.2) | 1.85 (0.47–7.33) | 0.11 (3.95) | 0.643 |
| TB type | |||||
| PTB+ | 84 (66.7) | 10 (11.9) | 1.00 | 1.00 | |
| PTB− | 19 (15.1) | 2 (10.5) | 0.87 (0.18–4.34) | 0.42 (0.04–4.77) | 0.483 |
| EPTB | 23 (18.3) | 2 (8.7) | 0.71 (0.14–3.47) | 0.50 (0.09–2.77) | 0.426 |
| Treatment history | |||||
| New TB cases | 119 (94.4) | 11 (9.2) | 1.00 | 1.00 | |
| Re-treatment TB cases | 7 (5.6) | 3 (42.9) | 7.36 (1.46–37.22) | 11.60 (1.70–78.92) | 0.012 |
| Residential areaa | |||||
| Non-pastoral | 54 (42.9) | 8 (14.8) | 1.00 | 1.00 | |
| Pastoral | 56 (44.4) | 5 (8.9) | 0.56 (0.17–1.85) | 0.46 (0.12–1.70) | 0.241 |
Note:
a
Participants with unknown residences were excluded from logistic regression analysis.
Abbreviations: MTBC, Mycobacterium tuberculosis complex; DR, drug resistance; TB, tuberculosis; PTB+, smear-positive pulmonary TB; PTB–, smear-negative pulmonary.